Its announcement comes within the heels of an identical licensing arrangement provided in February to Adastra Labs, which had till now focused on crafting cannabis extracts. Adastra's license also enables it to create and offer psilocybin and psilocin – hallucinogens far more commonly often called magic mushrooms that create results comparable to